A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants
Clinical trial NCT06554574 · COMPLETED
Trial details
- NCT number
- NCT06554574
- Sponsor
- Latigo Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-03
- Primary completion
- 2025-06-16
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.